NeuroPace, Inc. NPCE
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.10M | 22.83M | 22.07M | 26.59M | 23.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.10M | 22.83M | 22.07M | 26.59M | 23.35M |
| Cost of Revenue | 3.63M | 3.92M | 4.02M | 6.01M | 4.18M |
| Gross Profit | 19.47M | 18.91M | 18.05M | 20.58M | 19.17M |
| SG&A Expenses | 15.39M | 17.15M | 16.43M | 15.32M | 16.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.18M | 27.97M | 27.64M | 28.36M | 27.38M |
| Operating Income | -2.08M | -5.14M | -5.57M | -1.77M | -4.03M |
| Income Before Tax | -3.30M | -6.20M | -6.69M | -2.73M | -4.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.30M | -6.20M | -6.69M | -2.73M | -4.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 1.43M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.30M | -6.20M | -6.69M | -2.73M | -3.50M |
| EBIT | -2.08M | -5.14M | -5.57M | -1.77M | -4.03M |
| EBITDA | -2.00M | -5.08M | -5.51M | -1.69M | -3.97M |
| EPS Basic | -0.10 | -0.18 | -0.20 | -0.08 | -0.11 |
| Normalized Basic EPS | -0.06 | -0.11 | -0.12 | -0.05 | -0.09 |
| EPS Diluted | -0.10 | -0.18 | -0.20 | -0.08 | -0.11 |
| Normalized Diluted EPS | -0.06 | -0.11 | -0.12 | -0.05 | -0.09 |
| Average Basic Shares Outstanding | 34.35M | 34.10M | 33.72M | 33.39M | 33.13M |
| Average Diluted Shares Outstanding | 34.35M | 34.10M | 33.72M | 33.39M | 33.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |